Effective sensitizing dose of a gelled immunomodulating topical composition
AssigneePhio Pharmaceuticals Corp.
InventorsWilliam R. Levis, Leonard L. Kaplan, John G. Callahan
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods of treating warts and other human papilloma virus (HPV) skin infections. The present invention relates to compositions and methods of treating skin cancer.
Claims12
A method of treating skin cancer in a human patient, the method comprising administering to a first site on the skin of a human patient a sensitizing immunomodulating gel composition comprising from about 0.2% (w/w) to about 0.8% (w/w) diphenylcyclopropenone (DPCP), and subsequently administering to a second site on the skin of said patient a challenge immunomodulating gel composition comprising from about 0.01% (w/w) to about 0.4% (w/w) DPCP, wherein said skin cancer in the human patient is treated.
A method of treating skin cancer in a human patient, the method comprising administering to the skin of a human patient a sensitizing immunomodulating gel composition comprising about 0.4% (w/w) DPCP, and subsequently administering to the skin of the patient a challenge immunomodulating gel composition comprising DPCP in the range of about 0.04% (w/w) to about 0.1% (w/w) at 14 days and then biweekly administering to the skin of the patient a challenge immunomodulating gel composition comprising DPCP in the range of about 0.04% (w/w) to about 0.1% (w/w) for a sufficient amount of time.
A method of treating skin cancer in a human patient, the method comprising administering to the skin of a human patient a sensitizing immunomodulating gel composition comprising about 0.4% (w/w) DPCP, and subsequently administering to the skin of the patient a challenge immunomodulating gel composition comprising about 0.04% (w/w) DPCP at 14 days and then biweekly administering to the skin of the patient a challenge immunomodulating gel composition comprising about 0.04% (w/w) DPCP for a sufficient amount of time.
Dependencies are inferred from the claim text.